Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) EBITDA (2022 - 2025)

Historic EBITDA for Polomar Health Services (PMHS) over the last 4 years, with Q3 2025 value amounting to -$628808.0.

  • Polomar Health Services' EBITDA fell 14262.1% to -$628808.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 22580.45%. This contributed to the annual value of -$1.3 million for FY2024, which is 19478.26% down from last year.
  • According to the latest figures from Q3 2025, Polomar Health Services' EBITDA is -$628808.0, which was down 14262.1% from -$563333.0 recorded in Q2 2025.
  • In the past 5 years, Polomar Health Services' EBITDA ranged from a high of -$13518.0 in Q3 2022 and a low of -$689112.0 during Q4 2024
  • In the last 4 years, Polomar Health Services' EBITDA had a median value of -$190742.0 in 2024 and averaged -$300159.5.
  • Within the past 5 years, the most significant YoY rise in Polomar Health Services' EBITDA was 3779.52% (2023), while the steepest drop was 89628.64% (2023).
  • Polomar Health Services' EBITDA (Quarter) stood at -$151977.0 in 2022, then surged by 37.8% to -$94537.0 in 2023, then tumbled by 628.93% to -$689112.0 in 2024, then grew by 8.75% to -$628808.0 in 2025.
  • Its EBITDA stands at -$628808.0 for Q3 2025, versus -$563333.0 for Q2 2025 and -$415408.0 for Q1 2025.